Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Propofol for Inflammation in aSAH
NCT01565590Phase 3Terminated
- Sponsor
- University of Cincinnati
- Start
- Feb 2012
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in aneurysmal subarachnoid hemorrhage (SAH), sponsored by University of Cincinnati. Started Feb 2012; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT01565590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01565590.